Additionally, geopolitical factors can significantly impact the importation of APIs. Trade policies, tariffs, and political stability in supplier countries all influence the supply chain's reliability and cost. Recent global events, such as trade disputes and the COVID-19 pandemic, have highlighted the vulnerabilities within the pharmaceutical supply chain. Disruptions in transportation and logistics can lead to delays in receiving critical ingredients, which can halt production and affect drug availability in the market. As a result, pharmaceutical companies are increasingly looking to diversify their sourcing strategies to mitigate supply chain risks and ensure a more resilient approach.